Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-12 Purchase | 2021-02-12 6:00 pm | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 1,000 | $8 | $8,000 | 16,686 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-10 Option Award | 2023-08-14 4:06 pm | N/A 2033-08-10 | GRI BIO Inc. | GRI | Baker David Charles Director | 34,483 | $2.9 | 34,483 (Direct) | View |
| 2022-02-15 Option Award | 2022-03-01 5:04 pm | N/A 2032-02-15 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 61,000 | $5.63 | 61,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:06 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-02-12 Other | 2021-02-12 6:00 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 7,843 | $6.4 | 16,686 (Direct) | View |
Ownership | 2021-02-09 9:17 pm | 2019-01-15 2028-10-01 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 0 | $0 | 108,125 (Direct) | View |